Yoshihara, Fumiki
Matsuzawa, Yasushi
Nakatsuka, Kiyomasa
Kirigaya, Jin
Takeuchi, Ichiro
Kimura, Kazuo
Konishi, Masaaki
Tamura, Kouichi
Fukui, Kazuki
Tsukahara, Kengo
Shimizu, Hiroyuki
Iwabuchi, Keisuke
Yamada, Yu
Saka, Kenichiro
Sato, Yukihito
Ogawa, Masahiro
Hayakawa, Kayoko
Ohmagari, Norio
Ikeda, Syuhei
Akao, Masaharu
Shimomura, Hideki
Kihara, Yasuki
Yoshimoto, Akihiro
Morita, Masanori
Kumada, Norihiko
Ogata, Soshiro
Nishimura, Kunihiro
Arisato, Tetsuya
Matsuo, Miki
Kishida, Masatsugu
Yasuda, Satoshi
Ogawa, Hisao
Article History
Received: 27 June 2023
Revised: 4 March 2024
Accepted: 31 March 2024
First Online: 26 April 2024
Compliance with ethical standards
:
: FY reports research funding from AstraZeneca and Ono. KT reports honoraria from Novartis, AstraZeneca, Ono, Daiichi-Sankyo, Takeda, Otsuka, Bayer and Kyowa-Kirin, and research funding from AstraZeneca, Otsuka, Kaneka, and scholarship or donation from Bayer, Kyowa-Kirin, Otsuka, Takeda and Daiichi-Sankyo. SY reports honoraria from Daiichi Sankyo Co. Ltd. and Bayer Yakuhin, Ltd. and research funding from NEC Solution Innovators, Ltd., Daiichi Sankyo Co. Ltd. and Bayer Yakuhin, Ltd. and scholarship or donation from Abbott Medical Japan LLC, Amicus Therapeutics Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Company Ltd., Sumitomo Dainippon Pharma Co. Ltd., Roche Diagnostics K.K. and endowed departments by commercial entities from Abbott Medical Japan LLC, Medtronic Japan Co. Ltd., Tesco Co. Ltd., Terumo Co., Nihon Kohden Co., Japan Lifeline Co. Ltd., Sound Wave Innovation CO. LTD., ONO PHARMACEUTICAL CO. LTD., SHIONOGI & CO. LTD., ZEON MEDICAL INC., Nippon Shinyaku Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Company, Ltd., Takeda Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., BIOTRONIK JAPAN Co. Ltd., KANEKA MEDICAL PRODUCTS, FUKUDA DENSHI CO. LTD., and Philips Japan, Ltd. HO reports honoraria from Bayer Yakuhin. Other authors report no competing interests to disclose.
: The present study was approved by the National Cerebral and Cardiovascular Center Ethics Review (R20041). All procedures were performed in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.